Forbes & Co Profit Plummets 66% as Subsidiary Enters Insolvency

INDUSTRIAL-GOODSSERVICES
Whalesbook Logo
AuthorAnanya Iyer|Published at:
Forbes & Co Profit Plummets 66% as Subsidiary Enters Insolvency
Overview

Forbes & Company Limited reported a stark 66.19% year-on-year drop in standalone Q3 FY26 net profit to ₹284 Lakhs, with revenue falling 13.84% to ₹1,650 Lakhs. Consolidated PAT saw a 33.81% decline. Amidst key management changes, including CFO resignations, and its erstwhile subsidiary Forbes Technosys entering Corporate Insolvency Resolution Process (CIRP), the company faces significant headwinds.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

📉 The Financial Deep Dive

Forbes & Company Limited's unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025, reveal a sharp deterioration in performance.

The Numbers:

  • Standalone Performance:

    • Q3 FY26 Revenue: ₹1,650 Lakhs (YoY ↓ 13.84% from ₹1,915 Lakhs in Q3 FY25).
    • Q3 FY26 Profit After Tax (PAT): ₹284 Lakhs (YoY ↓ 66.19% from ₹840 Lakhs in Q3 FY25).
    • Nine Months FY26 Revenue: ₹5,666 Lakhs (YoY ↓ 3.14% from ₹5,850 Lakhs).
    • Nine Months FY26 PAT: ₹1,285 Lakhs (YoY ↓ 33.97% from ₹1,946 Lakhs).
    • Standalone EPS declined to ₹2.20 (Q3 FY26) from ₹4.68 (Q3 FY25).
  • Consolidated Performance:

    • Q3 FY26 Revenue: ₹1,780 Lakhs (YoY ↓ 13.88% from ₹2,067 Lakhs in Q3 FY25).
    • Q3 FY26 PAT: ₹419 Lakhs (YoY ↓ 33.81% from ₹633 Lakhs in Q3 FY25).
    • Nine Months FY26 Revenue: ₹5,895 Lakhs (YoY ↓ 17.77% from ₹7,169 Lakhs).
    • Nine Months FY26 PAT: ₹1,538 Lakhs (YoY ↓ 43.35% from ₹2,715 Lakhs).
    • Consolidated EPS fell to ₹3.29 (Q3 FY26) from ₹4.97 (Q3 FY25).

The Quality:

The significant drop in PAT, both standalone and consolidated, far outpaces the revenue decline, signaling considerable margin compression. The company also recognized an incremental impact of ₹164 Lakhs (standalone) and ₹173 Lakhs (consolidated) due to changes arising from new Labour Codes, accounted for as past service cost. This adds a non-operational financial burden.

Operational Distress & Management Changes:

Adding to the financial woes, the company announced several critical developments:

  • Its erstwhile subsidiary, Forbes Technosys Limited (FTL), has entered the Corporate Insolvency Resolution Process (CIRP). This signifies severe financial distress for the subsidiary, with potential financial implications for the parent.
  • The joint venture agreement with MACSA ID S.A. was terminated.
  • Forbes & Company Limited acquired the entire shareholding in Forbes Bradma Optimark Private Limited (FBOPL), making it a wholly-owned subsidiary from March 31, 2025. While this consolidates ownership, it comes amidst other negative developments.
  • Key management personnel changes include the resignation of Company Secretary Mr. Pritesh Jhaveri and Interim Chief Financial Officer Mr. Pavan Somani. The appointment of Mr. Jagannath Govale as the new CFO offers some stability, given his extensive experience.
  • A legal matter concerning Svadeshi Mills Company Limited remains pending final orders.

🚩 Risks & Outlook

The outlook for Forbes & Company Limited appears challenging, overshadowed by deep financial performance declines and significant operational risks. The entry of FTL into CIRP is a major red flag, potentially leading to write-downs or contingent liabilities. Management changes, particularly the departure of the interim CFO, coupled with a pending legal matter, add layers of uncertainty. Investors should monitor any further disclosures regarding FTL's CIRP and the company's ability to arrest the profit erosion and stabilize its operational structure. The limited review report from auditors also warrants careful attention, although specific adverse findings are not detailed here.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.